93 related articles for article (PubMed ID: 10878135)
1. Carbohydrate sulfation effects on growth of Pseudomonas aeruginosa.
Chance DL; Mawhinney TP
Microbiology (Reading); 2000 Jul; 146 ( Pt 7)():1717-1725. PubMed ID: 10878135
[TBL] [Abstract][Full Text] [Related]
2. Desulfurization of mucin by Pseudomonas aeruginosa: influence of sulfate in the lungs of cystic fibrosis patients.
Robinson CV; Elkins MR; Bialkowski KM; Thornton DJ; Kertesz MA
J Med Microbiol; 2012 Dec; 61(Pt 12):1644-1653. PubMed ID: 22918866
[TBL] [Abstract][Full Text] [Related]
3. Conversion of Pseudomonas aeruginosa to the phenotype characteristic of strains from patients with cystic fibrosis.
Speert DP; Farmer SW; Campbell ME; Musser JM; Selander RK; Kuo S
J Clin Microbiol; 1990 Feb; 28(2):188-94. PubMed ID: 2107198
[TBL] [Abstract][Full Text] [Related]
4. Interbacterial adhesion between Pseudomonas aeruginosa and indigenous oral bacteria isolated from patients with cystic fibrosis.
Komiyama K; Habbick BF; Gibbons RJ
Can J Microbiol; 1987 Jan; 33(1):27-32. PubMed ID: 3105855
[TBL] [Abstract][Full Text] [Related]
5. Binding of nonmucoid Pseudomonas aeruginosa to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis.
Sajjan U; Reisman J; Doig P; Irvin RT; Forstner G; Forstner J
J Clin Invest; 1992 Feb; 89(2):657-65. PubMed ID: 1737853
[TBL] [Abstract][Full Text] [Related]
6. Nonmucoid conversion of mucoid Pseudomonas aeruginosa induced by sulfate-stimulated growth.
Min KB; Lee KM; Oh YT; Yoon SS
FEMS Microbiol Lett; 2014 Nov; 360(2):157-66. PubMed ID: 25227776
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the Micronaut Merlin automated broth microtiter system with the standard agar dilution method for antimicrobial susceptibility testing of mucoid and nonmucoid Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Balke B; Hoy L; Weissbrodt H; Häussler S
Eur J Clin Microbiol Infect Dis; 2004 Oct; 23(10):765-71. PubMed ID: 15605183
[TBL] [Abstract][Full Text] [Related]
8. Sputum Active Polymyxin Lipopeptides: Activity against Cystic Fibrosis Pseudomonas aeruginosa Isolates and Their Interactions with Sputum Biomolecules.
Schneider-Futschik EK; Paulin OKA; Hoyer D; Roberts KD; Ziogas J; Baker MA; Karas J; Li J; Velkov T
ACS Infect Dis; 2018 May; 4(5):646-655. PubMed ID: 29566483
[TBL] [Abstract][Full Text] [Related]
9. Pseudomonas aeruginosa in the oral cavity and sputum of patients with cystic fibrosis.
Komiyama K; Tynan JJ; Habbick BF; Duncan DE; Liepert DJ
Oral Surg Oral Med Oral Pathol; 1985 Jun; 59(6):590-4. PubMed ID: 3925406
[TBL] [Abstract][Full Text] [Related]
10. Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis.
Pedersen SS
APMIS Suppl; 1992; 28():1-79. PubMed ID: 1449848
[TBL] [Abstract][Full Text] [Related]
11. Influence of nutrient media on the chemical composition of the exopolysaccharide from mucoid and non-mucoid Pseudomonas aeruginosa.
Marty N; Dournes JL; Chabanon G; Montrozier H
FEMS Microbiol Lett; 1992 Nov; 77(1-3):35-44. PubMed ID: 1459419
[TBL] [Abstract][Full Text] [Related]
12. Remodeling of O Antigen in Mucoid Pseudomonas aeruginosa via Transcriptional Repression of
Cross AR; Goldberg JB
mBio; 2019 Feb; 10(1):. PubMed ID: 30782665
[No Abstract] [Full Text] [Related]
13. Pattern of changes in the activity of enzymes of GDP-D-mannuronic acid synthesis and in the level of transcription of algA, algC and algD genes accompanying the loss and emergence of mucoidy in Pseudomonas aeruginosa.
Tavares IM; Leitão JH; Fialho AM; Sá-Correia I
Res Microbiol; 1999 Mar; 150(2):105-16. PubMed ID: 10209766
[TBL] [Abstract][Full Text] [Related]
14. The transcriptional regulator AlgR controls cyanide production in Pseudomonas aeruginosa.
Carterson AJ; Morici LA; Jackson DW; Frisk A; Lizewski SE; Jupiter R; Simpson K; Kunz DA; Davis SH; Schurr JR; Hassett DJ; Schurr MJ
J Bacteriol; 2004 Oct; 186(20):6837-44. PubMed ID: 15466037
[TBL] [Abstract][Full Text] [Related]
15. Identification of essential genes of Pseudomonas aeruginosa for its growth in airway mucus.
Alrahman MA; Yoon SS
J Microbiol; 2017 Jan; 55(1):68-74. PubMed ID: 28035597
[TBL] [Abstract][Full Text] [Related]
16. Rhesus θ-defensin-1 (RTD-1) exhibits in vitro and in vivo activity against cystic fibrosis strains of Pseudomonas aeruginosa.
Beringer PM; Bensman TJ; Ho H; Agnello M; Denovel N; Nguyen A; Wong-Beringer A; She R; Tran DQ; Moskowitz SM; Selsted ME
J Antimicrob Chemother; 2016 Jan; 71(1):181-8. PubMed ID: 26433781
[TBL] [Abstract][Full Text] [Related]
17. Pseudomonas aeruginosa displays an altered phenotype in vitro when grown in the presence of mannitol.
Moore JE; Rendall JC; Downey DG
Br J Biomed Sci; 2015; 72(3):115-9. PubMed ID: 26510267
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis.
Li Z; Kosorok MR; Farrell PM; Laxova A; West SE; Green CG; Collins J; Rock MJ; Splaingard ML
JAMA; 2005 Feb; 293(5):581-8. PubMed ID: 15687313
[TBL] [Abstract][Full Text] [Related]
19. Adherence of Pseudomonas aeruginosa to tracheal epithelium.
Marcus H; Austria A; Baker NR
Infect Immun; 1989 Apr; 57(4):1050-3. PubMed ID: 2494109
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity and reduction in pulmonary clearance of mucoid Pseudomonas aeruginosa.
Govan JR; Fyfe JA; Baker NR
Rev Infect Dis; 1983; 5 Suppl 5():S874-9. PubMed ID: 6419313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
